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Abstract
BACKGROUND: It is estimated that 30–70% of patients who undergo treatment for infertility are afflicted with 
endometriosis. 
AIM: The objectives of this study are to evaluate the impact of laparoscopic treated endometrioma compared to 
unexplained subfertility on the live birth rate in women undergoing in vitro fertilization (IVF)/intracytoplasmic sperm 
injection (ICSI). 
METHODS: This randomized prospective study included 120 women who contacted the department of IVF in the 
period from 2010 to 2015. Women were divided into two groups according to the findings obtained by laparoscopy. The 
treated endometrioma group (n = 60) with unilateral ovarian endometriomas and the non-endometriosis group (n = 60) 
with unexplained infertility undergoing the first cycle of IVF-embryo transfer (IVF-ET) were included in the study. In all 
participants, ICSI was used and all had fresh embryo transfer per cycle. The primary outcome was to live birth. 
RESULTS: Our results demonstrated that clinical pregnancy rates (p = 0.54) and live birth rate (p = 0.63) are similar. 
The preservation of a good ovarian response to stimulation by gonadotropins after laparoscopic ovarian cystectomy 
was presented. Laparoscopic cystectomy is followed by good IVF/ICSI outcome into the level expected in women 
with unexplained subfertility. 
CONCLUSION: Therefore, operative treatment is justified by not altering the live birth rate. Additional study is needed 
to be considered cystectomy before IVF as an effective approach for managing endometriosis-associated infertility.
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Introduction
Endometriosis is a complex disorder that affects 
5–10% of the female population of reproductive age. The 
exact incidence or prevalence is difficult to determine. 
Higher incidences of endometriosis have been reported 
in patients who undergo treatment for infertility and 
approximately 30–70% of patients with endometriosis 
may suffer from infertility [1]. About 60–75% of cases are 
ovarian endometriomas. Ovarian endometriomas >3 cm 
require adequate surgical treatment [2]. Surgery carries 
a risk of removing part of the normal ovarian tissue. 
The literature describes two techniques: Laparoscopic 
ovarian cystectomy, which involves stripping the cyst wall 
and laparoscopic vaporization of the internal layers of 
the endometriomas wall. The impact of endometriosis on 
fertility is not yet clear. Many factors have been suggested 
to cause infertility in women with endometriosis, including 
mechanical, immunological, and endocrinological [3], [4].
Using in vitro fertilization (IVF) treatment 
in patients with endometriosis can bypass certain 
disorders of the reproductive function. A number of 
studies report the role of ovarian endometriosis and 
its influence in the outcome of IVF fertilization. Data 
on the impact of endometriosis on the results of IVF 
treatment are controversial. Poor response to ovarian 
stimulation decreased oocyte retrieval rates, decreased 
fertilization, and implantation rates within the parameters 
that monitor the success of the IVF procedure have all 
been implicated. Several studies have reported that 
laparoscopic surgery of ovarian endometriosis can 
damage the ovarian reserve implicated a possibility of 
lower ovarian response to gonadotropins [5].
One Cochrane review compared the 
reproductive outcomes between laparoscopic surgical 
interventions and diagnostic laparoscopy in patients 
with minimal to mild endometriosis. The meta-
analysis demonstrated an advantage of laparoscopic 
surgery compared to diagnostic laparoscopy in clinical 
pregnancy rate and live birth rate [6]. Furthermore, 
randomized control trials of surgical or expectant 
management for endometriosis prior IVF assessed 
the effectiveness of surgery for improving reproductive 
outcome [7]. In addition, the European Society of Human 
Reproduction and Embryology (ESHRE) guideline 
suggested that laparoscopic ovarian cystectomy prior 
IVF is recommended if an ovarian endometrioma is 
4 cm or more in diameter with improve access to follicles 
and possibly improves the ovarian response [8].
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However, results retrieved from studies and 
meta-analysis depicts a diverse pattern of IVF success, 
underlying the involvement of individual parameters in 
the appearance of the final outcome [9]. There is an 
insufficient data in the literature, which compared IVF 
outcome in women with treated endometriosis and 
women with other diagnostic entities for infertility. The 
aim of our study was to investigate whether laparoscopic 
treated endometrioma may adversely affect on the results 
of IVF/intracytoplasmic sperm injection (ICSI) outcomes 
with particular reference on the clinical pregnancy rate 
per embryo transfer cycle and live birth rate.
Materials and Methods
Patient selection
The randomized prospective study 
encompassed the period from 2010 to 2015, during 
which 120 patients were performed. Exclusion criteria 
for the women were endometriosis Stage IV; serum 
concentration of follicle-stimulating hormone (FSH) 
>15 IU/l; older than 41 year; with an abnormal ovarian 
reserve (antral follicle count <5–7 follicles or anti-
Mullerian hormone <0.5–1.1 ng/mL), with a previous 
poor ovarian response; women with additional causes 
for infertility such as polycystic ovarian syndrome, 
uterine malformation, underlying immune conditions, as 
well as patients with infectious disease such as human 
immunodeficiency virus. Inclusion criteria for the women 
were minimum 2 years of infertility, regular menstrual 
cycle (intervals 25–35), normal serum concentration or 
prolactin, free thyroxin, and thyroid-stimulating hormone. 
The patients who had undergone laparoscopic surgery 
for endometriosis and who failed to become pregnant 
within 1 year after surgery have been evaluated. Only 
patients with laparoscopic excision of the ovarian 
endometrioma cyst were included in this study group. 
The non-endometriosis group was patients with 
unexplained subfertility who underwent IVF/ICSI during 
the same period of time. All patients had a diagnostic 
or surgical laparoscopy. Only women whose partners’ 
have normal semen analyses were reviewed. Only 
cycles with long luteal protocol for IVF and ICSI were 
included in the study. In all participants, ICSI was used 
and all had fresh embryo transfer per cycle.
Study group
Endometriosis was diagnosed by laparoscopy 
and scored according to the revised classification of the 
American Fertility Society [10]. Patients were divided 
into two groups according to the findings obtained by 
laparoscopy. The endometriosis group of patients (60) 
was with ovarian endometriomas >3 cm, treated by 
cystectomy with stripping technique.
The non-endometriosis group (n = 60) was 
with unexplained subfertility. The laparoscopic findings 
in the group were normal, with no pathology of 
gynecologic organs. We have analyzed the parameters 
for ovarian stimulation with gonadotropins in a long 
luteal protocol and parameters that define the results 
of IVF fertilization. Such data would be useful for 
patient counseling and will supply further information 
for the impact of endometriosis on pregnancy rate in 
contemporary IVF/ICSI treatment.
Ovarian stimulation
A long stimulation protocol was used in all 
patients. Downregulation was initiated with buserelin 
acetate (Suprefact, Sanofi Aventis, Kallithea, Athens, 
Greece) during the mid-luteal phase. Injections of 
recombinant follitropin beta (Puregon, N.V. Oregon, 
OS, The Netherlands) were initiated on the 3rd day of 
the menstrual cycle. The doses were adjusted to the 
patient’s age and the numbers and size of follicles 
and the estradiol level. We followed during the 
controlled ovarian stimulation a protocol set by our IVF 
department. With ultrasonography and laboratory tests, 
we evaluated several parameters such as estradiol (E2), 
number and size of follicles, endometrium thickness, 
and gonadotropins administration. We started with rFSH 
administration on the 3rd day of the menstrual cycle 
when the E2 level was <30 pg/ml. When the estradiol 
level was ±200 pg/ml per follicle ≥18 mm in diameter, 
chorionic gonadotropin (human chorionic gonadotropin 
injection [hCG], 10,000 IU; Pregnyl, N.V. Organon, OS, 
The Netherlands) was administered for triggering the 
maturation of oocytes.
Ethical consideration
This randomized prospective study was 
approved by the Clinical Research and Research Ethics 
Committees (code: 455). We obtain from all participants 
written consent.
Statistical analysis
Statistical analysis of the data was performed 
in the statistical program Statistica 7.1. The analysis 
of the series with attributive marks, percentages of the 
structure (%), was determined and tested using the 
Pearson’s Chi-square test and the exact Fisher test 
(p). Descriptive statistics were used for the distribution 
of data (Kolmogorov–Smirnov test; Lilliefors test; and 
Shapiro–Wilks test). The age difference between 
patients was tested with analysis of variance (F;p)/Tukey 
post hoc (p). The difference in the analyzed parameters 
between patient groups in case of deviation from a 
normal distribution was tested with Kruskal–Wallis 
ANOVA by ranks (H). The statistical difference in the 
analyzed parameters between two groups of patients 
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was tested with Mann–Whitney U-test (Z). Fertilization 
rate, implantation rate, clinical pregnancy rate, and the 
birth rate in all groups (%) were made. Differences were 
considered significant when p < 0.05.
Results
Patient characteristics are shown in Table 1. 
There were no significant differences in age F = 1.54 and 
p > 0.05 (p = 0.34), duration of infertility F = 1.97 and 
p > 0.05 (p = 0.27), or body mass index F = 1.63 and 
p > 0.05 (p = 0.19) among the groups.






Age (years) 32.10 ±4 .35 31.20 ± 3.81 0.34
Body mass index 24.2 ± 3.5 21.8 ± 2.6 0.19
Duration of infertility (years) 4.7 ± 2.3 4.0 ± 2.6 0.27
Chi-square test for categorical and Student’s t-test for continuous data. p>0.05 compared to unexplained 
subfertility.
The mean age was not more than 36 years, 
an important role in the further processing of data. 
The female age is undoubtedly the most significant 
factor influencing the IVF outcome. In addition, in all 
patients included in the study, a serum anti-Mullerian 
hormone was in reference value before surgery. In 
the parameters for ovarian stimulation, no significant 
statistical differences appear in all four groups. 
Descriptive statistics of the level of estradiol, the day 
of hCG administration, the number of ampoules, and 
the thickness of the endometrium were very similar. In 
this study, we remarked that in endometriosis patients 
with ovarian cystectomy, a longer stimulation with 
gonadotropin was required, and at the same time, 
more ampoules were used, but without any statistical 
significance p > 0.05 (p = 0.35). Using descriptive 
statistics, it was noted that the average number of 
mature oocytes (MII) was lower in patients with ovarian 
cystectomy (7.70 ± 2.91), compared to unexplained 
subfertility group, but both parameters were without any 
statistical significance p > 0.05 (p = 0.13) (Table 2).






Total gonadotropin dose (units) 2711.40 ± 16.91 2250.50 ± 14.38 0.35
Follicles 9.17 ± 4.62 14.33 ± 7.50 0.21
Mature oocytes 7.70 ± 2.91 11.37 ± 4.13 0.13
Estradiol peak 1515.53 ± 517.10 1598.33 ± 521.11 0.65
Duration of ovarian stimulation 
(days)
10.29 ± 2.30 9.63 ± 2.61 0.71
Chi-square test for categorical and Student’s t-test for continuous data. p>0.05 compared to unexplained 
subfertility.
In terms of the parameters of IVF outcome, no 
significant statistical correlations were found between the 
groups. This study clearly showed that fertilization rates 
were not affected in patients undergoing laparoscopic 
excisional surgery for ovarian endometrioma. Clinical 
pregnancy rate between groups, respectively, varying 
from 53.3% to 35.90% and the live birth rate 43.3% to 
50% (Table 3).






Fertilization rate (%) 77.06 70.38 0.67
Embryos/cycle 5.93 ± 4.09 8.01 ± 7.96 0.83
Transferred embryos/cycle 2.30 ± 1.53 2.60 ± 1.13 0.79
Implantation rate per embryo transfer (%) 30.43 35.90 0.43
Pregnancy rate per embryo transfer 
cycle (%)
53.3 35.90 0.54
Live birth rate (%) 43.3 50 0.63
Data presented as breakdown and one-way ANOVA. p>0.05 compared to unexplained subfertility.
The results among groups were analyzed, but 
they remained without any statistical significance. None 
of the patients experienced any complications from 
controlled ovarian stimulation, trigger, or oocyte retrieval.
Discussion
The high prevalence of endometriosis imposes 
the need for correct management between infertile 
women. There is still no consensus on the impact of 
endometriosis on IVF outcome and whether ovarian 
endometrioma should be removed in subfertility women 
before IVF.
Harb et al. published a systematic review and 
meta-analysis on the effect of endometriosis on IVF 
outcome [11]. Studies compared IVF outcome in women 
with endometriosis and women without endometriosis. 
This meta-analysis showed that fertilization rates were 
reduced in the stage of minimal and mild endometriosis, 
and there was a decrease in the implantation rate 
and clinical pregnancy rate in women with the stage 
of moderate and severe endometriosis undergoing 
IVF treatment. The explanation is found in abnormal 
endometrial pinopode formation, an embryotoxic 
milieu, and progesterone resistance in women with 
endometriosis [12], [13], [14]. These factors play a crucial 
part in reducing fertility in women with endometriosis.
In Harb review, a 14% reduction in live birth 
rates was observed in patients with stage III/IV 
endometriosis. However, this did not reach statistical 
significance.
Furthermore, Hamdan et al. were noticed in 
his review significantly higher cancellation rate in 
women with endometriosis undergoing IVF/ICSI 
in contrast with those without endometriosis. [15]. 
Furthermore, baseline FSH levels were higher when 
compared with women with no endometriosis although 
AFC and total stimulation dose were comparable 
between bought groups. In terms of the impact on 
surgical intervention for endometrioma on IVF/ICSI 
outcome, many studies evaluated in Hamdan review 
demonstrated similar clinical and live births between 
surgically treated endometrioma versus women with 
intact endometrioma. Women with endometrioma who 
had surgical treatment had besides a lower AFC and 
required higher total gonadotropin stimulation dose. 
Both groups had similar baseline FSH. In addition, 
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women with surgically treated endometrioma versus 
normal contralateral ovary had retrieved a lower 
number of oocytes from the treated ovary. There is no 
doubt that surgery on endometriosis has a detrimental 
impact on ovarian reserve [16]. Therefore, it is justified 
to evaluate ovarian reserve before operative treatment 
even in younger patients. Individualization of care for 
women with endometriosis before IVF/ICSI may help 
optimize their IVF/ICSI results [17].
There is a general consensus that IVF should 
be recommended in infertile women who fail to become 
pregnant after surgical treatment [9]. A number of 
studies have taken into consideration the impact 
of IVF in pregnancy rate in patients with surgically 
treated endometriosis. Namely, the study of Dechanet 
presented that the surgery before IVF increasing the 
pregnancy rate in women with endometriomas [18]. 
Gonadotropin-releasing hormone (GnRH) agonists 
have also been reported to increase pregnancy rate 
compared to GnRH antagonists [19]. The recent study 
showed that surgery for big endometrioma could be 
required before IVF to facilitate access to follicles during 
oocyte retrieval or to improve the ovarian response 
to controlled ovarian stimulation. Prolonged pituitary 
downregulation in women with surgically treatment 
endometriosis may be helpful to increase the clinical 
pregnancy rate in subsequent IVF cycles [20]. This 
integrated approach (surgery and IVF-ET) produced a 
pregnancy rate of 56.1% compared to a significantly 
lower pregnancy rate of only 37.4% after surgery 
alone [21].
Crochet performed a retrospective case–
control study, to investigate the progression of 
endometriosis after IVF treatment in women having 
previously undergone surgical intervention [22]. The 
findings suggested that IVF is not responsible for the 
aggravation of endometriosis. During the controlled 
ovarian stimulation, it was shown that the pregnancy 
rate, oocytes, and functionality of the embryo were not 
affected by the presence of endometriomas, regardless 
of whether the endometriomas were surgically treated 
or not [23]. The pregnancy rate is negatively associated 
with the degree of endometriosis and the optimal 
time for the IVF procedure [24]. It is considered to be 
between 7 and 25 months after surgery.
Regarding the risk of miscarriage when 
endometriosis is present, IVF appears to be an 
independent factor [25]. Care should also be taken 
to endometriosis fertility index (EFI) because it 
represents a new staging system and has proved 
to be a useful tool in the hands of doctors [26]. EFI 
is used to predict fertility sequentially to surgery. 
Regarding the women who underwent surgery, 
a follow-up assessment of EFI ≥5–12 months 
postoperatively was indicated the implementation of 
IVF-ET procedure [27].
Our study has highlighted the lack of 
clinical studies examining the surgically treated 
endometrioma with women with no endometriosis. 
The study was in line with ESHRE guidelines on 
endometrioma management. With surgery, women 
not only get relief from clinical symptoms but also 
there is better accessibility of the ovaries for oocyte 
retrieval. Furthermore, better results after surgically 
treated endometriosis can be expected as a result 
of the restoration of normal anatomy. We noticed 
that fertilization rates are not affected in patients 
with laparoscopic cystectomy. Findings revealed 
that parameters for ovarian stimulation and fertility 
outcome are similar in both groups. However, women 
with surgically treated endometrioma had a lower 
oocyte retrieval and required higher FSH stimulation 
compared with unexplained infertility, but results 
are without any statistical significance. Therefore, 
we conclude that the operative treatment of ovarian 
unilateral endometrioma has no adverse effect on IVF 
outcome.
Limitation
By limiting the study to a fresh ET cycle, it 
was not possible to assess the cumulative outcome 
including the use of all frozen embryos. The findings of 
the study should be confirmed in future large trials with 
the possibility to include additional significant covariates 
in the statistical model.
Conclusion
We can conclude that surgery does not 
adversely affect the examined parameters for ovarian 
stimulation and the outcome of IVF. The theoretical 
risk of loss of ovarian tissue during surgery remains 
but can be avoided by carefully preserving normal 
ovarian tissue. Surgical management should be 
individualized for women with endometriomas and 
attention to be given to the preoperative ovarian 
reserve status. Comparing the outcome of IVF/ET 
results, there was no significant difference in women 
with laparoscopic treated endometrioma and non-
endometriosis group.
The most important clinical outcome is the live 
birth rate, which was similar in both groups. Finally, 
the efficiency of laparoscopic procedures in managing 
endometriosis-related infertility is crucial by return live 
birth rate in the level expected in the women without 
endometriosis.
It is important to note that most studies agree 
with the fact that individual patient factors have the 
most important role in the IVF outcome. According to 
that, individual treatment based on the expertise of the 
physician and needs of the patient is recommended in 
patients with endometriosis-associated infertility.
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